Скачать или смотреть SHOCKING Weight Loss results: Tirzepatide (Mounjaro) vs. Semaglutide (Ozempic) - SURMOUNT-5 trial!

The results are IN! 💥 A major new clinical trial, SURMOUNT-5, directly compared two of the most talked-about weight loss medications: Tirzepatide (known as Mounjaro® or Zepbound®) and Semaglutide (known as Ozempic® or Wegovy®). This study focused specifically on adults with obesity who DO NOT have type 2 diabetes.

Join us as we break down the SURMOUNT-5 findings:

Which drug led to significantly MORE average weight loss?

How did they stack up on reducing waist circumference (belly fat)?

What percentage of people achieved dramatic weight loss (e.g., 20-30% of body weight)?

What were the key differences in side effects?

TIMESTAMPS:

0:00 - Intro: The Big Comparison

0:20 - Understanding the SURMOUNT-5 Study

0:50 - How Researchers Compared Tirzepatide & Semaglutide

1:30 - WEIGHT LOSS RESULTS: Who Came Out on Top? 🏆

2:30 - Shrinking Waistlines & Meeting Big Goals

3:10 - Beyond Weight: Other Health Improvements

3:40 - A Look at the Side Effects

4:20 - The Bottom Line: What SURMOUNT-5 Tells Us

4:50 - Always Talk To Your Doctor!

If you're exploring weight management options or just want to stay informed about the latest medical breakthroughs, this video explains the SURMOUNT-5 results in an easy-to-understand way.

Medications Discussed:

Tirzepatide (Mounjaro®, Zepbound®)

Semaglutide (Ozempic®, Wegovy®)

DISCLAIMER: The information in this video is for educational purposes only and is not a substitute for professional medical advice. Please consult your doctor to discuss your individual health needs and treatment options.

👇 Got questions or reactions to the SURMOUNT-5 trial? Drop them in the comments!
🔔 Like this video and SUBSCRIBE for more updates on weight management and health!

#WeightLossDrugs #SURMOUNT5trial #TirzepatideResults #SemaglutideResults #MounjaroWeightLoss #ZepboundWeightLoss #OzempicForWeightLoss #WegovyResults #Obesity #MedicalNews